市場調査レポート

商品コード

皮下ドラッグデリバリー市場の2030年までの予測：製品タイプ、適応症、流通チャネル、地域別の世界分析

Subcutaneous Drug Delivery Devices Market Forecasts to 2030 - Global Analysis By Product, Type, Indication, Distribution Channel and By Geography

出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 610,008円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 771,697円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 933,386円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,102,425円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、皮下ドラッグデリバリーの世界市場は2023年に309億米ドルを占め、予測期間中にCAGR 11.3％で成長し、2030年には654億米ドルに達する見込みです。

皮下ドラッグデリバリーデバイスと呼ばれる医療機器は、患者の皮下、つまり皮膚の下に薬剤を投与するために使用されます。このドラッグデリバリー方式は、薬剤の循環中への一定かつ継続的な放出を可能にするため、副作用が少なく、より安定した治療効果が得られることから、他の方式よりも好まれています。皮下ドラッグデリバリーシステムは、皮下に挿入する注射器、分配システム、医薬品容器で構成されます。

全米多発性硬化症協会によると、2017年には米国で推定100万人の成人が多発性硬化症を患っていると報告されています。

慢性疾患の増加

糖尿病、自己免疫疾患、心血管疾患などの慢性疾患の有病率の増加が、皮下ドラッグデリバリーデバイスの需要を牽引しています。これらのデバイスは、これらの疾患の長期的な管理のために薬物を投与する効果的な方法を提供します。したがって、慢性疾患の急速な増加が市場の成長を促進すると予想されます。

健康意識の欠如

新興国や未開発国では、医薬品やさまざまな病気、ドラッグデリバリー技術に関する知識が乏しいです。ヘルスケア施設が不十分なため、慢性疾患関連の死亡事故が増加しています。農村部の住民のほとんどは、発見されずに治療されないままです。さらに、皮下ドラッグデリバリーデバイスの使用は、薬剤や薬剤投与機器のコストが高いため、多くの国で制限されています。これは市場拡大を阻害しかねない重要な要素です。

バイオシミラーおよび生物製剤への需要の高まり

世界の皮下ドラッグデリバリーデバイス市場の市場参入企業は、生物学的製剤やバイオシミラー医薬品の急速な普及により、多くの成長機会を得ています。皮下ドラッグデリバリーシステムに対する世界の需要は、慢性的な症状を治療するためのさまざまな薬剤に対するニーズの高まりによって牽引されています。皮下投与を必要とすることが多い生物学的製剤やバイオシミラーの使用が増加しているため、これらの薬剤に合わせた特殊な送達装置の需要が高まっています。

不適切な使用による針刺し損傷

針刺し損傷とドラッグデリバリー過量投与は、正しい情報や指示がないまま皮下投与デバイスを不適切に使用した場合に生じる可能性のある問題の2つに過ぎないです。このことは、患者が複数のドラッグデリバリーの選択肢の中から選択することをより困難にします。さらに、注射針に関連した血液を媒介とする感染症の危険性が、結局は大きな障害となるかもしれないです。

COVID-19の影響：

皮下投薬デバイス市場は、ヘルスケア分野全体と同様に、COVID-19の流行によって大きな影響を受けています。在宅治療、遠隔ヘルスケア、通院回数の削減が重視されるようになった結果、自己投与デバイスの需要がますます高まっています。この流行により、効率的なドラッグデリバリー技術の重要性が注目され、皮下ドラッグデリバリー市場への技術革新と投資に拍車がかかっています。

予測期間中、ウェアラブル注射器分野が最大になる見込み

予測期間中、ウェアラブル注射器分野が最大となる見込みです。これは、針刺し傷害の増加や注射の使用による血液媒介性疾患のリスクの増加に関連しています。高粘度、高容量の生物学的製剤は、ウェアラブル注射器によって卓越した効率で投与されます。ウェアラブル注射器と呼ばれるデジタル薬剤投与ツールは便利で、患者が適切なタイミングで正確な量を投与できるよう支援します。

予測期間中、神経疾患分野のCAGRが最も高くなると予想されます。

神経疾患分野は、予測期間中に最も高いCAGRが見込まれます。これらのデバイスは、長期間にわたって制御された安定した薬物放出を行うことができます。てんかんやパーキンソン病など、一定した投薬レベルが重要な神経疾患では、この制御された放出が症状を効果的に管理するのに役立ちます。これらの装置は、患者の快適性を考慮して設計されることが多く、治療の侵襲性を最小限に抑えることができます。

最大のシェアを占める地域

予測期間中、北米が最大の市場シェアを占めると予測されます。これは、さまざまな慢性疾患の有病率が上昇し、国民の間で医薬品やドラッグデリバリーデバイスに対する需要が高まっているためです。同市場は、ヘルスケアインフラが整備されていること、同地域に複数の大手メーカーが存在すること、各メーカーがさまざまな開発戦略をとっていること、医療支出が増加していることなど、多くの重要な理由によって成長しています。

CAGRが最も高い地域：

予測期間中、アジア太平洋地域のCAGRが最も高いと予測されます。これは主に、この地域の人々の不健康な食習慣のために糖尿病人口が急速に増加していることに起因しています。可処分所得の増加、糖尿病管理に関する意識の高まり、ヘルスケア支出の増加は、近い将来の市場成長を促進する主な要因です。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第11章企業プロファイル

Medtronic Plc
Gerresheimer AG
Elcam Medical Group
Insulet Corporation
Ypsomed AG
Becton, Dickinson and Company
PharmaJet
Unilife Corporation
In life Sciences
West Pharmaceutical Services, Inc.
Novo Nordisk
Eli Lilly
Merck
AstraZeneca
Amgen
Enable Injections
Consort Medical Plc
Wilhelm Haselmeier GmbH & Co. KG

図表

List of Tables

Table 1 Global Subcutaneous Drug Delivery Devices Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
Table 4 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
Table 5 Global Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
Table 6 Global Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
Table 7 Global Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
Table 8 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
Table 9 Global Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
Table 10 Global Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 11 Global Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 12 Global Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
Table 13 Global Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 14 Global Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
Table 15 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
Table 16 Global Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
Table 17 Global Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
Table 18 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
Table 19 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
Table 20 Global Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 21 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 22 Global Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 23 Global Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 24 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 25 North America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 26 North America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 27 North America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
Table 28 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
Table 29 North America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
Table 30 North America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
Table 31 North America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
Table 32 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
Table 33 North America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
Table 34 North America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 35 North America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 36 North America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
Table 37 North America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 38 North America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
Table 39 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
Table 40 North America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
Table 41 North America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
Table 42 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
Table 43 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
Table 44 North America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 45 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 46 North America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 47 North America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 48 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 49 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 50 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 51 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
Table 52 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
Table 53 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
Table 54 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
Table 55 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
Table 56 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
Table 57 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
Table 58 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 59 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 60 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
Table 61 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 62 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
Table 63 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
Table 64 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
Table 65 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
Table 66 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
Table 67 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
Table 68 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 69 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 70 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 71 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 72 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 73 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 74 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 75 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
Table 76 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
Table 77 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
Table 78 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
Table 79 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
Table 80 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
Table 81 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
Table 82 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 83 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 84 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
Table 85 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 86 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
Table 87 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
Table 88 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
Table 89 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
Table 90 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
Table 91 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
Table 92 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 93 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 94 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 95 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 96 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 97 South America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 98 South America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 99 South America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
Table 100 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
Table 101 South America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
Table 102 South America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
Table 103 South America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
Table 104 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
Table 105 South America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
Table 106 South America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 107 South America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 108 South America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
Table 109 South America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 110 South America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
Table 111 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
Table 112 South America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
Table 113 South America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
Table 114 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
Table 115 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
Table 116 South America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 117 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 118 South America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 119 South America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 120 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 121 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 122 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 123 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
Table 124 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
Table 125 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
Table 126 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
Table 127 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
Table 128 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
Table 129 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
Table 130 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 131 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 132 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
Table 133 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 134 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
Table 135 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
Table 136 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
Table 137 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
Table 138 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
Table 139 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
Table 140 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 141 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
Table 142 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 143 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 144 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)

Product Code: SMRC24650

According to Stratistics MRC, the Global Subcutaneous Drug Delivery Devices Market is accounted for $30.9 billion in 2023 and is expected to reach $65.4 billion by 2030 growing at a CAGR of 11.3% during the forecast period. Medical equipment called subcutaneous drug delivery devices is used to give patients medication subcutaneously, or under the skin. This method of drug delivery is preferred over others because it enables the drug's constant and continuous release into circulation, leading to less side effects and more consistent therapeutic advantages. Subcutaneous drug delivery systems consist of a syringe inserted under the skin, a distribution system, and a pharmaceutical container.

According to the National Multiple Sclerosis Society, an estimated 1.0 million adults were reported to be living with multiple sclerosis in the U.S. in 2017.

Market Dynamics:

Driver:

Rise in Chronic Diseases

Increasing prevalence of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions has driven the demand for subcutaneous drug delivery devices. These devices offer an effective way to administer medication for long-term management of these ailments. Therefore, the rapidly growing prevalence of chronic diseases is expected to drive the growth of the market.

Restraint:

Lack of health awareness

In emerging and undeveloped economies, there's a dearth of knowledge about pharmaceuticals, various ailments, and drug delivery technologies. Chronic illness-related fatalities rise as a result of inadequate healthcare facilities. Most rural residents continue to go undetected and untreated. Furthermore, the use of subcutaneous drug delivery devices is limited in a number of countries by the high cost of medications and drug administration equipment. This is a significant element that might impede market expansion.

Opportunity:

Growing demand for biosimilar and biologics

The market participants in the worldwide subcutaneous drug delivery devices market have a number of growth opportunities thanks to the quick rise in popularity of biologic and biosimilar medications. Global demand for subcutaneous drug delivery systems is being driven by the increasing need for different medications to treat chronic conditions. The growing use of biologics and biosimilars, which often require subcutaneous administration, has bolstered the demand for specialized delivery devices tailored for these medications.

Threat:

Improper use may give rise to needle stick injuries

Needlestick injuries and drug overdoses are only two of the issues that can arise from using subcutaneous medication delivery devices improperly without the right information and instruction. This can make it more difficult for the patients to choose between several drug delivery options. Furthermore, the dangers of blood-borne infections linked to injection needles might end up being a significant obstacle.

COVID-19 Impact:

The market for subcutaneous medication delivery devices has been significantly impacted by the COVID-19 epidemic, as has the whole healthcare sector. Self-administration devices are becoming more and more in demand as a result of the growing emphasis on home-based treatment, remote healthcare, and reducing hospital visits. The epidemic has brought attention to the significance of efficient medication delivery techniques, spurring innovation and investment in the subcutaneous drug delivery market.

The wearable injectors segment is expected to be the largest during the forecast period

The wearable injectors segment is expected to be the largest during the forecast period. This is linked to the increase in needle stick injuries as well as the increased risk of blood-borne illnesses from injection usage. The high-viscosity, high-volume biologic medications are administered with exceptional efficiency by the wearable injectors. Digital medicine administration tools called wearable injectors are convenient and assist patients in giving precise dosages at the appropriate times.

The neurological disorders segment is expected to have the highest CAGR during the forecast period

The neurological disorders segment is expected to have the highest CAGR during the forecast period. These devices can provide a controlled and steady release of medications over an extended period. For neurological disorders where consistent medication levels are crucial, such as in epilepsy or Parkinson's disease, this controlled release can help manage symptoms effectively. These devices are often designed for patient comfort, minimizing the invasiveness of treatments.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the increased prevalence of various chronic diseases resulted in the huge demand for drugs and drug delivery devices amongst the population. The market is growing due to a number of significant reasons, including the presence of improved healthcare infrastructure, the presence of multiple major manufacturers in the region and the different developmental strategies they have followed, and rising healthcare spending.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. This is majorly attributed to the rapidly growing diabetic population in the region owing to the unhealthy food habits of the people. The rising disposable income, growing awareness regarding the diabetes management, and rising healthcare expenditure are the major factors that will drive the growth of the market in the forthcoming future.

Key players in the market:

Some of the key players in Subcutaneous Drug Delivery Devices market include Medtronic Plc, Gerresheimer AG, Elcam Medical Group, Insulet Corporation, Ypsomed AG, Becton, Dickinson and Company, PharmaJet, Unilife Corporation, In life Sciences , West Pharmaceutical Services, Inc., Novo Nordisk, Eli Lilly, Merck, AstraZeneca, Amgen, Enable Injections, Consort Medical Plc and Wilhelm Haselmeier GmbH & Co. KG.

Key Developments:

In November 2023, The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Zepbound™ (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.

In October 2023, Eli Lilly gives $20M upfront cash injection to Elektrofi in next-gen subcutaneous drug collab. Eli Lilly has tapped up drug delivery specialist Elektrofi to see whether the biotech's microparticle formulation technology could produce the next generation of subcutaneously administered therapies.

Products Covered:

Prefilled Syringes
Auto-Injectors
Wearable Injectors
Pen Injectors
Needle-Free Injectors
Other Products

Types Covered:

Disposable
Reusable

Indications Covered:

Neurological Disorders
Oncology Disorders
Auto-immune Disorders
Ophthalmic Disorders
Allergy & Infectious Disorders
Hormonal Disorders
Other Indications

Distribution Channels Covered:

Hospitals
Retail Pharmacies
Online Pharmacies
Other Distribution Channels

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Subcutaneous Drug Delivery Devices Market, By Product

5.1 Introduction
5.2 Prefilled Syringes
5.3 Auto-Injectors
5.4 Wearable Injectors
5.5 Pen Injectors
5.6 Needle-Free Injectors
5.7 Other Products

6 Global Subcutaneous Drug Delivery Devices Market, By Type

6.1 Introduction
6.2 Disposable
6.3 Reusable

7 Global Subcutaneous Drug Delivery Devices Market, By Indication

7.1 Introduction
7.2 Neurological Disorders
7.3 Oncology Disorders
7.4 Auto-immune Disorders
7.5 Ophthalmic Disorders
7.6 Allergy & Infectious Disorders
7.7 Hormonal Disorders
7.8 Other Indications

8 Global Subcutaneous Drug Delivery Devices Market, By Distribution Channel

8.1 Introduction
8.2 Hospitals
8.3 Retail Pharmacies
8.4 Online Pharmacies
8.5 Other Distribution Channels

9 Global Subcutaneous Drug Delivery Devices Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Medtronic Plc
11.2 Gerresheimer AG
11.3 Elcam Medical Group
11.4 Insulet Corporation
11.5 Ypsomed AG
11.6 Becton, Dickinson and Company
11.7 PharmaJet
11.8 Unilife Corporation
11.9 In life Sciences
11.10 West Pharmaceutical Services, Inc.
11.11 Novo Nordisk
11.12 Eli Lilly
11.13 Merck
11.14 AstraZeneca
11.15 Amgen
11.16 Enable Injections
11.17 Consort Medical Plc
11.18 Wilhelm Haselmeier GmbH & Co. KG

皮下ドラッグデリバリー市場の2030年までの予測：製品タイプ、適応症、流通チャネル、地域別の世界分析

Subcutaneous Drug Delivery Devices Market Forecasts to 2030 - Global Analysis By Product, Type, Indication, Distribution Channel and By Geography

COVID-19の影響：

最大のシェアを占める地域

CAGRが最も高い地域：

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の皮下ドラッグデリバリーデバイス市場：製品別

第6章 世界の皮下ドラッグデリバリーデバイス市場：タイプ別

第7章 世界の皮下ドラッグデリバリーデバイス市場：適応症別

第8章 世界の皮下ドラッグデリバリーデバイス市場：流通チャネル別

第9章 世界の皮下ドラッグデリバリーデバイス市場：地域別

第10章 主な発展

第11章 企業プロファイル